Study of aetiological factors and clinical profiles of neonatal jaundice in the special newborn care unit of tertiary care hospital of Government Medical College, Rajouri, Jammu and Kashmir union territory: a hospital-based study
DOI:
https://doi.org/10.18203/2320-6012.ijrms20230357Keywords:
Neonatal jaundice, Physiological, ABo incompatibility, Rh incompatibility, IdiopathicAbstract
Background: Neonatal hyperbilirubinemia may be physiological or pathological. Neonatal hyperbilirubinemia is a common condition requiring inpatient treatment and monitoring and many time requires readmission to hospital. Estimated incidence of jaundice in neonates is 60% to 84% of late term and term infants. Present study was undertaken to study clinical profile of neonates with jaundice at our tertiary care centre.
Methods: This prospective observational study was conducted in neonates with jaundice admitted in SNCU ward during study period with serum bilirubin more than 10 ml/dl.
Results: During study period 339 neonates were considered for presented study. 192 newborns (56.63%) developed jaundice after 72hrs. of birth. Only 28.90% newborns developed jaundice within 24 hrs. Of birth. 61.65% babies were male as compared to 38.34% female babies. Jaundice was most commonly noted in babies delivered at more than 34 weeks gestational age (60.17%), while only 10.02% babies were delivered between 28-32 weeks gestational age. 2500- 4000 gm birth weight babies were 60.14% while only 39.82% babies had weight less than 2500 gms. Incidence of neonatal jaundice was 60.06%, 30.38%, 08.55% in vaginal, caesarean section and instrumental delivery respectively. Physiological jaundice (30.67%), prematurity (25.30%), Rh incompatibility (10.91%), breast feeding/jaundice (10%), ABo incompatibility (6.19) and idiopathic (5.01%) were most common causes noted in our study.
Conclusions: Male gender, 2500-4000 gm birth weight, vaginal delivery, physiological delivery, prematurity were common causes associated neonatal jaundice in our study. Parent counselling and monitoring of baby is most important in management of neonatal jaundice.
Metrics
References
Barabara JS, Kliegman RM. Jaundice and Hyperbilirubinemia in the new born. In: Kliegman RM, Behrman HB. Jenson HP, editors. Nelson textbook of paediatrics, 17th ed. Philadelphia: Elsevier Saunders. 2004;592-8.
Zipursky A, Blencowe H, Khanna R, Sgro M, Ebbesen F, Ebbesen F, et al. Neonatal newborn: incidence and impairment estimates for 2010 at regional and global levels. Pediatr Res. 2013;74(1):86-100.
Mwaniki MK, Atieno M, Lawn JE, Newton CRJC. Long-term neurodevelopmental outcomes after intrauterine and neonatal insults: A systematic review. Lancet. 2012;379:445-52.
Maisels MJ, Watchko JF, Bhutani VK, Stevenson DK. An approach to the management of hyperbilirubinemia in the preterm infant less than 35 weeks of gestation. J Perinatol. 2012;32(9):660-4.
Stokowski, Laura A. Fundamentals of phototherapy for neonatal jaundice. Adv Neonat Care. 2011;11.
Narang A, Kumar P, Kumar R. Neonatal jaundice in very low birth weight babies. Indian J Pediatr. 2001;68:307-9.
Escobar GJ, Greene JD, Hulac P, Kincannon E, Bischoff K, Gardner MN, et al. Rehospitalisation after birth hospitalisation: patterns among infants of all gestations. Arch Dis Child. 2005;90(2):125-31.
Kliegman RM, Stanton BMD, St Geme J, Schor NF, Behrman RE. Nelson Textbook of Pediatrics. 19th Edition. St Louis, MO: Elsevier Saunders. 2011.
Mishra S, Agarwal R, Deorari AK, Paul VK. Jaundice in the newborns. Indian J Pediatr. 2008;75:157-63.
Bhutani VK. On Evidence based issues regarding the neonatal hyperbilirubinemia. Paediatrics Rev. 2005;114:130-53.
Najib K, Saki F, Hemmati F, Inaloo S. Incidence, risk factors and causes of severe neonatal hyperbilirubinemia in South of Iran. Iran Red Cres Med J. 2013;15(3).
Pathak U, Chawla D, Kaur S, Jain S. Bilirubin nomogram for prediction of significant hyperbilirubinemia in north Indian neonates. Indian Pediatr. 2013;50(4):383-9.
Varvarigou A, Fouzas S, Skylogianni E, Mantagou L, Bougioukou D, Mantagos S. Transcutaneous bilirubin nomogram for prediction of significant neonatal hyperbilirubinemia. Pediatrics. 2009;124(4):1052-9.
Keren R, Bhutani VK, Luan X, Nihtianova S, Cnaan A, Schwartz JS. Identifying newborns at risk of significant hyperbilirubinaemia: a comparison of two recommended approaches. Arch Dis Child. 2005;90(4):415-21.
Stoll BJ, Kliegman RM. Jaundice and hyperbilirubinemia in the newborn. Nelson textbook of pediatrics. 19th ed. Philadelphia: WB Saunders. 2011;562-96.
Sarici SU, Serdar MA, Karkmaz A, Erdem G, Oran O, Tekinalp G, et al. Incidence, course and prediction of hyperbilirubinemia in near term and term newborns. Pediatrics. 2014;113(4):775-80.
Porter ML, Dennis BL. Hyperbilirubinemia in the term newborn. Am Fam Physician. 2002;65(4):599-606.
Gartner LM, Herschel M. Jaundice and breast-feeding. Pediatr Clin North Am. 2001;48:389-99.
Singh SK, Singh SN, Kumar M, Tripathi S, Bhriguvanshi A, Chandra T, et al. Etiology and clinical profile of neonates with pathological unconjugated hyperbilirubinemia with special reference to Rhesus (Rh) D, C, and E incompatibility: A tertiary care centre experience. Clin Epidemiol Global Health. 2016;4:95-100.
Heydarian F, Majdi M. Hydarian F, Majdi M. Severe neonatal hyperbilirubinemia; Causes and contributing factors leading to exchange transfusion at Ghaem Hospital in Mashhad. Acta Med Iran. 2010;48(6):399-402.
Shetty A, Kumar BS. A study of neonatal hyperbilirubinemia in a tertiary Care Hospital. Int J Med Sci Public Health. 2014;3:1289-92.
Kaplan M, Wong RJ, Sibley E, Stevenson DK. Neonatal jaundice and liver disease. 9th edition. Martine RJ, Fanaroff AA, Walsh MC, editors. Neonatal – Perinatal Medicine: Diseases of Fetus and Infant. Volume 2. St Louis: Elsevier Mosby. 2011;1443.
Downloads
Published
How to Cite
Issue
Section
